Economy

Most Active Volume Stock: NewLink Genetics Corporation (NLNK)

In recent trading day NewLink Genetics Corporation (NLNK) stock showed the move of -5.83% with the closing price of $16.64.

A better-ranked stock in the Medical - Biomedical and Genetics industry is Akari Therapeutics PLC AKTX, which now carries a Zacks Rank #1 (Strong Buy).

Taking a broader look brokerage firms' analysts on the street with an expectant view have Newlink Genetics Cor (NASDAQ:NLNK) high price target of $29 and with a conservative view have low price target of $19.

A number of other research firms have also weighed in on NLNK. Bogle Inv Mngmt L P De invested in 0.12% or 176,077 shares. On the other side, analysts now consider NewLink Genetics Corporation a neutral, and a technical analysis of the stock is setting somewhat negative outlook for now.

NewLink Genetics Corporation (NLNK) saw -10.93 million in free cash flow last quarter, representing a quarterly net change in cash of -10.46 million. Robert W. Baird reaffirmed an outperform rating and set a $25.00 target price on shares of NewLink Genetics Corporation in a report on Monday, June 5th.

Among 5 analysts covering NewLink Genetics (NASDAQ:NLNK), 5 have Buy rating, 0 Sell and 0 Hold.

The stock of NewLink Genetics Corp (NASDAQ:NLNK) is a huge mover today! The stock's market capitalization is $519.87 million. NewLink Genetics has $32 highest and $18 lowest target.

The company's 50 day moving average is $7.52 and its 200 day moving average is $12.81. Analysts are forecasting earnings of $-0.8 on a per share basis this quarter. The consensus mean EPS for the current quarter is at $-0.77 derived from a total of 5 estimates from the analysts who have weighed in on projected earnings.

03/30/2017 - NewLink Genetics Corporation was upgraded to "buy" by analysts at SunTrust. On average, equities research analysts forecast that NewLink Genetics Corporation will post ($2.82) EPS for the current fiscal year.

WARNING: This piece was first published by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another website, it was stolen and reposted in violation of US & worldwide trademark & copyright legislation. The original version of this story can be viewed at https://www.truebluetribune.com/2017/09/11/newlink-genetics-corporation-nlnk-cut-to-strong-sell-at-valuengine.html.

Several large investors have recently made changes to their positions in NLNK. However, if the CDW shares go below $59.12 then it would indicate a much weaker market for the company. Eqis Capital Management Inc. now owns 32,999 shares of the biotechnology company's stock valued at $243,000 after acquiring an additional 183 shares during the period. American International Group has an ownership of 13,321 stocks of the biotechnology firms shares valued $321,000 after scooping up an extra 880 shares through out the previous quarter, Lastly, Northwest Wealth Management upgraded its holdings in NewLink Genetics Corporation by 3.1% through out the 2nd period. Advisor Group Inc. now owns 18,082 shares of the biotechnology company's stock valued at $133,000 after acquiring an additional 600 shares during the period. State Street Corp lifted its holdings in shares of NewLink Genetics Corporation by 1.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in NewLink Genetics Corporation by 0.7% in the third quarter. Renaissance Technology Llc holds 0% in NewLink Genetics Corp (NASDAQ:NLNK) or 145,800 shares. Institutional investors own 54.78% of the company's stock.

Its additional HyperAcute Cellular Immunotherapy product candidates in clinical development include tergenpumatucel-L and dorgenmeltucel-L for patients with advanced lung cancer and melanoma, respectively.



Like this

loading...
loading...

Latest


18 September 2017
Haley: Trump's fire, fury comment 'not an empty threat'
MR JON ALTERMAN, senior vice-president of the Centre for Strategic and International Studies, on the United Nations meeting. Analysts have said the North has shown rapid improvements in its ballistic missile and nuclear technologies.

18 September 2017
Trump's Supporters, Protesters Hold Rival Rallies in Washington, DC
Organisers had hoped to attract a million people to Washington DC for a massive demonstration showing their support for the U.S. president.

18 September 2017
Chargers set off celebratory cannon after losing to Dolphins
Spanos struck a deal with Los Angeles Rams owner Stan Kroenke to play in his Inglewood stadium, scheduled to be ready in 2020. Henry, who was expected to take over for Antonio Gates , played just 23 snaps in the opener and wasn't targeted AT ALL.

18 September 2017
United Kingdom police recover number of items after arresting 18-year-old man
As a precautionary measure, we evacuated the surrounding buildings and set up cordons within a 100-metre radius. Of those injured, 19 victims were taken to hospital by ambulance, while 11 presented themselves for treatment.

18 September 2017
Power outage causing extensive delays on these subway lines
In a statement sent out just before 5:30 pm, Cuomo slammed the outage as "completely unacceptable". The utility lost seven feeders, according to an MTA spokesman.

18 September 2017
Castleark Management LLC Has $9291000 Position in Cheniere Energy, Inc. (LNG)
The company reported $0.02 earnings per share for the quarter, hitting the Zacks' consensus estimate of $0.02. (NYSEMKT: LNG ). According to Thomson Reuters, sell-side analysts are predicting a consensus target price of $124.20 on company stock.

18 September 2017
Apple Inc. Has a Tough iPhone Problem to Solve in 2018
The iPhone 8 and iPhone 8 Plus will be available across the country from September 29 via offline and online retail stores. Apple Watch Serries 3 will be available in market from 22 September while Pre-order are open from 15 September.

18 September 2017
Portola Pharmaceuticals, Inc. (PTLA) Rating Reiterated by Oppenheimer Holdings, Inc
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website . Schwab Charles Investment Management Inc. boosted its stake in Portola Pharmaceuticals by 3.1% during the second quarter.

18 September 2017
Gary Neville reacts to Man United's 4-0 win over Everton
Asked about City, who beat Watford 6-0 on Saturday, Mourinho said: "Today I didn't think one single second about Man City". So it's even more hard and even more important.

18 September 2017
Navient Corporation (NASDAQ:NAVI) Announces $0.16 Quarterly Dividend
The company reported $0.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.44 by $0.01. Whereas 4 of them predict the stock is a hold. (NASDAQ:AMAT) has "Hold" rating given on Friday, August 14 by Nomura.